Medical device design & manufacturing · 1,001–5,000 employees · USA · ElectroNeek customer since 2020
Who they are
UFP Technologies is a designer and manufacturer of custom medical devices, sub-assemblies, components and packaging, using highly specialized foams, films and plastics. Its production and quality environment is document-dense by regulation as much as by volume.
What they run on ElectroNeek
UFP Technologies has been an ElectroNeek customer since 2020 — one of the longest-running deployments on the platform. Keith Cote, VP of IT: “Our first proof of concept was easy to create — we worked through the full implementation confident we’d made a good choice.”
Automation in regulated manufacturing
In medical manufacturing, the paperwork is the process: purchase orders and supplier confirmations against the ERP, quality documentation that must be complete before product moves, and customer order intake where a mistyped line becomes a compliance event.
Agents handle intake and reconciliation — reading orders and confirmations, posting to the ERP, assembling documentation packets, and stopping to ask a human whenever something doesn't match. Every action is logged, which turns audits from archaeology into a report.
Typical outcomes for this profile
Outcome figures below reflect typical results for organizations automating comparable processes on the ElectroNeek platform; they are illustrative benchmarks, not client-reported metrics.
- 70%+ — of order-intake touch time removed in comparable deployments
- Days — from proof-of-concept to first live workflow — as UFP's team experienced
- 5.1 mo — median payback across agent deployments industry-wide
Common questions
Does automation hold up under regulated-industry audits?
It helps: agents write a complete decision log — what data was read, what action was taken, when a human stepped in — so the audit trail is a byproduct, not a project.
How fast can a manufacturer see the first working automation?
UFP's experience is typical of the platform: a proof of concept in days on real data, then a controlled path to production.